Skip to content
Catalyst

1,7-dimethylxanthinePapers

Papers about 1,7-dimethylxanthine

papers
105
41 years, by papers

Newest first

51 to 100 of 105

Every paper here, unless its row says otherwiseIndexed under 1,7-dimethylxanthine in PubMed's chemical list

  • Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.

    Clinical pharmacology and therapeutics2005PMID 16198659

  • Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.

    European journal of clinical pharmacology2005PMID 16261361

  • Salivary caffeine metabolic ratio in alcohol-dependent subjects.

    European journal of clinical pharmacology2004PMID 15022032

  • Serum metabolite/caffeine ratios as a test for liver function.

    Journal of clinical pharmacology2004PMID 15051740

  • Caffeine suppresses TNF-alpha production via activation of the cyclic AMP/protein kinase A pathway.

    International immunopharmacology2004PMID 15313438

  • Effect of a divided caffeine dose on endurance cycling performance, postexercise urinary caffeine concentration, and plasma paraxanthine.

    Journal of applied physiology (Bethesda, Md.2003PMID 12482764

  • Antagonism of adenosine receptors by caffeine and caffeine metabolites in equine forebrain tissues.

    American journal of veterinary research2003PMID 12602592

  • Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects.

    Clinical pharmacology and therapeutics2003PMID 12621391

  • Paraxanthine/caffeine ratio: as an index for CYP1A2 activity in polycyclic aromatic hydrocarbons exposed subjects.

    Journal of the Medical Association of Thailand2003PMID 12930004

  • CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.

    Cancer epidemiology, biomarkers & prevention2002PMID 11927498

  • Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.

    Biochemical pharmacology2002PMID 12110375

  • Caffeine potentiates the discriminative-stimulus effects of nicotine in rats.

    Psychopharmacology2002PMID 12172692

  • Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells.

    Biochemical pharmacology2001PMID 11226378

  • In vivo effect of clarithromycin on multiple cytochrome P450s.

    Drug metabolism and disposition: the biological fate of chemicals2001PMID 11408369

  • Urinary biomarkers for assessing dietary exposure to caffeine.

    Food additives and contaminants2001PMID 11761118

  • Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population.

    British journal of clinical pharmacology2000PMID 10671909

  • The effects of acute falciparum malaria on the disposition of caffeine and the comparison of saliva and plasma-derived pharmacokinetic parameters in adult Nigerians.

    European journal of clinical pharmacology2000PMID 10877011

  • Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test.

    Pharmacogenetics1999PMID 10376760

  • Validation of a high-performance liquid chromatography assay for quantification of caffeine and paraxanthine in human serum in the context of CYP1A2 phenotyping.

    Biomedical chromatography1999PMID 10416066

  • Chronic effects of xanthines on levels of central receptors in mice.

    Cellular and molecular neurobiology1999PMID 10456233

  • Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women.

    Journal of clinical pharmacology1999PMID 10471985

  • Maternal serum paraxanthine, a caffeine metabolite, and the risk of spontaneous abortion.

    The New England journal of medicine1999PMID 10572151

  • Omeprazole weakly inhibits CYP1A2 activity in man.

    International journal of clinical pharmacology and therapeutics1999PMID 10584979

  • Serum caffeine and paraxanthine as markers for reported caffeine intake in pregnancy.

    Annals of epidemiology1998PMID 9491935

  • Simple high-performance liquid chromatography method for the simultaneous determination of serum caffeine and paraxanthine following rapid sample preparation.

    Journal of chromatography1998PMID 9613939

  • Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.

    Cancer epidemiology, biomarkers & prevention1996PMID 8877060

  • Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.

    Pharmacogenetics1996PMID 9156694

  • Analysis of within-subject variation of caffeine metabolism when used to determine cytochrome P4501A2 and N-acetyltransferase-2 activities.

    Cancer epidemiology, biomarkers & prevention1995PMID 7742721

  • Sympathomimetic effects of paraxanthine and caffeine in humans.

    Clinical pharmacology and therapeutics1995PMID 8529334

  • Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.

    Pharmacogenetics1994PMID 7920690

  • Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.

    Biochemical pharmacology1994PMID 8204093

  • Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.

    Drug metabolism and disposition: the biological fate of chemicals1993PMID 8095225

  • Caffeine metabolism and epinephrine responses during exercise in users and nonusers.

    Journal of applied physiology (Bethesda, Md.1993PMID 8226485

  • Comparison of hepatic drug-oxidizing activity after simultaneous administration of two probe drugs, caffeine and trimethadione, to human subjects.

    Pharmacology & toxicology1993PMID 8441739

  • Excretion of caffeine and its primary degradation products into bile.

    Journal of hepatology1993PMID 8445222

  • Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.

    Pharmacogenetics1992PMID 1302044

  • Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.

    European journal of pharmacology1991PMID 1828237

  • Lack of interaction between lomefloxacin and caffeine in normal volunteers.

    Antimicrobial agents and chemotherapy1991PMID 2069371

  • Paraxanthine displaces the binding of [3H]SCH 23390 from rat striatal membranes.

    European journal of pharmacology1990PMID 2194822

  • Effect of paraxanthine on FFA mobilization after intravenous caffeine administration in humans.

    Journal of applied physiology (Bethesda, Md.1990PMID 2312486

  • The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

    British journal of clinical pharmacology1989PMID 2713214

  • Interaction between oral ciprofloxacin and caffeine in normal volunteers.

    Antimicrobial agents and chemotherapy1989PMID 2729942

  • Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.

    The Journal of pharmacology and experimental therapeutics1989PMID 2913277

  • Correlation of caffeine elimination and Child's classification in liver cirrhosis.

    Klinische Wochenschrift1989PMID 2921843

  • 4-quinolones inhibit biotransformation of caffeine.

    European journal of clinical pharmacology1988PMID 2853056

  • Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines.

    Food and chemical toxicology1988PMID 3058562

  • Caffeine and its dimethylxanthine metabolites in two cases of caffeine overdose: a cause of falsely elevated theophylline concentrations in serum.

    Journal of analytical toxicology1988PMID 3072449

  • Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.

    Drug metabolism and disposition: the biological fate of chemicals1987PMID 2882985

  • Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.

    British journal of clinical pharmacology1986PMID 3756065

  • Quantitative assessment of caffeine partial clearances in man.

    British journal of clinical pharmacology1986PMID 3756066

The next 5 papers

← Previous 50